CNH Partners »

Carmell Therapeutics Corp - US shares owned by CNH Partners

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by CNH Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $22k 96k 0.23
2023-09-30 $22k 97k 0.23

More positions owned by CNH Partners

Karuna Therapeutics Ord
Splunk Note 1.125% 6/1 (Principal)
ImmunoGen
Albertsons Cos Common Stock (ACI)
Cerevel Therapeutics Hldng I (CERE)
United States Steel Corporation (X)
Wayfair Note 3.250% 9/1 (Principal)
PNM Resources (PNM)
Etsy Note 0.250% 6/1 (Principal)
Amedisys (AMED)
Array Technologies Note 1.000%12/0 (Principal)
Gores Holdings Ix Class A Com (GHIX)
Hess (HES)
Lci Inds Note 1.125% 5/1 (Principal)
Pioneer Natural Resources (PXD)

View all positions for CNH Partners

Top funds holding Carmell Therapeutics Corp - US

Balyasny Asset Management
Millennium Management
OZ Management
Highbridge Capital Management
Exos TFP Holdings
CNH Partners
Walleye Trading Advisors
Cowen And Company
Flow Traders US
Saba Capital Management
Whitebox Advisors
Wolverine Asset Management
Ancora Advisors

View all funds holding Carmell Therapeutics Corp - US